Tandem Diabetes Care has received Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users.

Tandem Diabetes Care announced plans to link its automated insulin delivery systems with an upcoming wearable monitor from Abbott that aims to measure glucose as well as ketone levels. The dual sensor ...

Analysts have set 12-month price targets for Tandem Diabetes Care, revealing an average target of $19.78, a high estimate of ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced it has signed a multi-year collaboration agreement ...

Tandem Diabetes Care, Inc. ( NASDAQ: TNDM) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 9:15 AM EDT ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...

In the last three months, 4 analysts have published ratings on Tandem Diabetes Care TNDM, offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their ...

Oppenheimer analyst Suraj Kalia assumed coverage of Tandem Diabetes (TNDM) with an Outperform rating and price target of $22, down from $44. The ...